FDA Drug Application (019065) for NOVOLIN N by NOVO NORDISK INC

Back to FDA Applications sponsored by NOVO NORDISK INC

Application Number019065
Product Number001
FormINJECTABLE;INJECTION
Dosage100 UNITS/ML
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameNOVOLIN N
Active IngredientINSULIN SUSP ISOPHANE SEMISYNTHETIC PURIFIED HUMAN

Active IngredientCount
List of drugs with Active Ingredient INSULIN SUSP ISOPHANE RECOMBINANT HUMAN6
List of drugs with Active Ingredient INSULIN SUSP ISOPHANE SEMISYNTHETIC PURIFIED HUMAN4


Back to FDA Applications sponsored by NOVO NORDISK INC